Article
Vitamin D receptor gene polymorphism and prostate cancer risk.
The Prostate - 1 Apr 2002
Gsur Andrea, Madersbacher Stephan, Haidinger Gerald, Schatzl Georg, Marberger Michael, Vutuc Christian, Micksche Michael
Abstract excerpt
BACKGROUND: 1,25-dihydroxyvitamin D, the active form of vitamin D, exerts antiproliferative effect on prostatic cells, mediated through the vitamin D receptor. In a case-control study, we examined whether the vitamin D receptor (VDR) gene polymorphism in exon 9 could affect prostate cancer susceptibility. METHODS: One hundred ninety newly diagnosed prostate cancer patients and 190 age-matched men with benign...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
